Cargando…

Genetic variation in complement regulators and susceptibility to age-related macular degeneration

OBJECTIVES: Age-related macular degeneration (AMD) is the commonest cause of blindness in Western populations. Risk is influenced by age, genetic and environmental factors. Complement activation appears to be important in the pathogenesis and associations have been found between AMD and genetic vari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cipriani, Valentina, Matharu, Baljinder K., Khan, Jane C., Shahid, Humma, Stanton, Chloe M., Hayward, Caroline, Wright, Alan F., Bunce, Catey, Clayton, David G., Moore, Anthony T., Yates, John R.W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657157/ https://www.ncbi.nlm.nih.gov/pubmed/22024702 http://dx.doi.org/10.1016/j.imbio.2011.09.002

Ejemplares similares

Analysis of copy number variation at DMBT1 and age-related macular degeneration
por: Polley, Shamik, et al.
Publicado: (2016)

Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration
por: Ansari, Morad, et al.
Publicado: (2013)

Identification of a Rare Coding Variant in Complement 3 Associated with Age-related Macular Degeneration
por: Zhan, Xiaowei, et al.
Publicado: (2013)

Complement factor I and age-related macular degeneration
por: Alexander, Philip, et al.
Publicado: (2014)

Is preventable sight loss truly preventable? An exploration of a public health indicator for sight loss due to age-related macular degeneration in England
por: Brown, Kelsey, et al.
Publicado: (2022)

A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin(® )(Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design
por: Patel, Praveen J, et al.
Publicado: (2008)

The complement system in age-related macular degeneration
por: Armento, Angela, et al.
Publicado: (2021)

Systemic Complement Activation in Age-Related Macular Degeneration
por: Scholl, Hendrik P. N., et al.
Publicado: (2008)

“Complement-ary” Therapies for Age-Related Macular Degeneration
por: Lin, Jonathan B., et al.
Publicado: (2022)

Role of Complement in the Onset of Age-Related Macular Degeneration
por: Piri, Niloofar, et al.
Publicado: (2023)

Age-Related Maculopathy Susceptibility 2 and Complement Factor H Polymorphism and Intraocular Complement Activation in Neovascular Age-Related Macular Degeneration
por: Kato, Yutaka, et al.
Publicado: (2022)

Beyond factor H: The impact of genetic-risk variants for age-related macular degeneration on circulating factor-H-like 1 and factor-H-related protein concentrations
por: Cipriani, Valentina, et al.
Publicado: (2021)

Correction: Systemic Complement Activation in Age-Related Macular Degeneration
por: Scholl, Hendrik P. N., et al.
Publicado: (2008)

Correction: Systemic Complement Activation in Age-Related Macular Degeneration
por: Scholl, Hendrik P. N., et al.
Publicado: (2008)

Complement system and age-related macular degeneration: drugs and challenges
por: Wu, Jiali, et al.
Publicado: (2019)

Complement System and Potential Therapeutics in Age-Related Macular Degeneration
por: Park, Young Gun, et al.
Publicado: (2021)

Susceptibility to advanced age-related macular degeneration and alleles of complement factor H, complement factor B, complement component 2, complement component 3, and age-related maculopathy susceptibility 2 genes in a Mexican population
por: Buentello-Volante, Beatriz, et al.
Publicado: (2012)

Positioning In Macular hole Surgery (PIMS): statistical analysis plan for a randomised controlled trial
por: Bell, Lauren, et al.
Publicado: (2017)

Zinc Supplementation Inhibits Complement Activation in Age-Related Macular Degeneration
por: Smailhodzic, Dzenita, et al.
Publicado: (2014)

Targeting the Complement Cascade for Treatment of Dry Age-Related Macular Degeneration
por: Patel, Prem N., et al.
Publicado: (2022)

PIMS (Positioning In Macular hole Surgery) trial – a multicentre interventional comparative randomised controlled clinical trial comparing face-down positioning, with an inactive face-forward position on the outcome of surgery for large macular holes: study protocol for a randomised controlled trial
por: Pasu, Saruban, et al.
Publicado: (2015)

Association between genetic variation of complement C3 and the susceptibility to advanced age-related macular degeneration: a meta-analysis
por: Zhang, Jun, et al.
Publicado: (2018)

Structural basis for complement factor H–linked age-related macular degeneration
por: Prosser, Beverly E., et al.
Publicado: (2007)

Age-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?
por: Warwick, Alasdair, et al.
Publicado: (2014)

Regulation of age-related macular degeneration-like pathology by complement factor H
por: Toomey, Christopher B., et al.
Publicado: (2015)

Peptide redesign for inhibition of the complement system: Targeting age-related macular degeneration
por: Mohan, Rohith R., et al.
Publicado: (2016)

Interaction of Complement Factor H and Fibulin3 in Age-Related Macular Degeneration
por: Wyatt, M. Keith, et al.
Publicado: (2013)

Associations of the intestinal microbiome with the complement system in neovascular age-related macular degeneration
por: Zysset-Burri, Denise C., et al.
Publicado: (2020)

Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option
por: Qin, Shuqi, et al.
Publicado: (2021)

Differential and Altered Spatial Distribution of Complement Expression in Age-Related Macular Degeneration
por: Demirs, John T., et al.
Publicado: (2021)

Y chromosome mosaicism is associated with age-related macular degeneration
por: Grassmann, Felix, et al.
Publicado: (2018)

An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration
por: Biggs, Robyn M., et al.
Publicado: (2022)

Associations between the Complement System and Choroidal Neovascularization in Wet Age-Related Macular Degeneration
por: Jensen, Emilie Grarup, et al.
Publicado: (2020)

Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration
por: Kato, Yutaka, et al.
Publicado: (2020)

Rare complement factor I variants associated with reduced macular thickness and age-related macular degeneration in the UK Biobank
por: Tzoumas, Nikolaos, et al.
Publicado: (2022)

Copy number variation in the complement factor H-related genes and age-related macular degeneration
por: Kubista, Katharina E., et al.
Publicado: (2011)

Complement factor B polymorphism 32W protects against age-related macular degeneration
por: Hughes, Anne E., et al.
Publicado: (2011)

The effect of complement factor B gene variation on age-related macular degeneration in Iranian patients
por: Roshanipour, Nasrin, et al.
Publicado: (2019)

Complement factors and reticular pseudodrusen in intermediate age-related macular degeneration staged by multimodal imaging
por: Lynch, Anne M, et al.
Publicado: (2020)

Complement activation, lipid metabolism, and mitochondrial injury: Converging pathways in age-related macular degeneration
por: Tan, Li Xuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iac23phiojbi4igf6umetvn59g